To the full analysis
Vetoquinol stock: growth
VETO.PAVetoquinol reported $582.53M in revenue for fiscal 2025, down 2.5% on the prior year, up 4.2% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
4.9%
per year from 2006 to 2025, per share 4.6%
Earnings (Annual rate)
7%
per year from 2006 to 2025, per share 6.1%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 4.2% | 4.4% | 4.9% |
| Revenue per share | 4.1% | 4.4% | 4.6% |
| Earnings | 24.4% | 9.0% | 7.0% |
| Earnings per share | 24.8% | 9.2% | 6.1% |
| Free cash flow | no data | 6.3% | no data |
| Free cash flow per share | no data | 6.3% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $234.46M | $17.53M | −$2.42M |
| 2007 | $258.59M | $20.66M | $31.89M |
| 2008 | $259.73M | $20.57M | $14.45M |
| 2009 | $284.84M | $20.18M | $35.87M |
| 2010 | $312.53M | $24.66M | $29.48M |
| 2011 | $314.85M | $25.15M | $22.57M |
| 2012 | $330.54M | $25.01M | $27.84M |
| 2013 | $332.13M | $26.13M | $23.97M |
| 2014 | $349.38M | $28.55M | $34.42M |
| 2015 | $379.65M | $26.77M | $30.89M |
| 2016 | $388.23M | $30.84M | $37.41M |
| 2017 | $390.24M | $38.6M | $33.4M |
| 2018 | $407.72M | $40.18M | $29.48M |
| 2019 | $438.8M | $31.68M | $47.18M |
| 2020 | $473.68M | $21.3M | −$59.23M |
| 2021 | $577.62M | $69.66M | $62.9M |
| 2022 | $598.13M | $53.18M | $44.21M |
| 2023 | $586.49M | $61.57M | $77.99M |
| 2024 | $597.48M | $65.03M | $75.51M |
| 2025 | $582.53M | $63.49M | $56.9M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 11 Sep 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.